Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
Entero and ADC-like biotech Journey pen reverse merger
Entero Therapeutics is inking a reverse merger with ADC rival biotech Journey Therapeutics.
Gabrielle Masson
Nov 13, 2024 10:40am
Alentis raises $181M series D to bring ADCs to the clinic
Nov 12, 2024 7:00am
AstraZeneca, Daiichi pull lung cancer BLA for Enhertu follow-up
Nov 12, 2024 5:27am
Ideaya pushes ahead with Biocytogen bispecific ADC bet
Nov 11, 2024 8:50am
BigHat, Synaffix collab outfits AI science with ADC tech
Nov 4, 2024 11:07am
AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC
Sep 8, 2024 12:22pm
